Space and entry motion sickness

Principles of Clinical Medicine for Space Flight

Volumn , Issue , 2008, Pages 211-222

  Ortega, Hernando J ^a   Harm, Deborah L ^b  

^a USAF   (United States)

^b NASA JOHNSON SPACE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950186630     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68164-1_10     Document Type: Chapter

References (77)

1. Davis JR, Jennings RT, Beck BG, et al. Treatment efficacy of intramuscular promethazine for space motion sickness. Aviat Space Environ Med 1993; 64:230-233.
2. Jennings RT. Managing space motion sickness. J Vestib Res 1998; 8:67-70.
3. Reschke MF, Harm DL, Parker DE, et al. Neurophysiological aspects: Space motion sickness. In: Nicogossian AE, Leach Huntoon C, Pool SL (eds.), Space Physiology and Medicine, 3rd edn. Philadelphia, PA: Lea and Febiger; 1994:228-260.
4. Reschke MF, Kornilova LM, Harm DL, et al. Neurosensory and sensory-motor function. In: Leach Huntoon CS, Antipov VV, Grigoriev AI (eds.), Humans in Space Flight. Vol. 3, Book 1. Reston, VA: American Institute of Aeronautics and Astronautics; 1996:135-193. Nicogossian AE, Mohler SR, Gazenko OG, Grigoriev AI (series eds.), Space Biology and Medicine.
5. Gillingham KK, Previc FH. Spatial orientation in flight. In: DeHart RL (ed.), Fundamentals of Aerospace Medicine. Baltimore, MD: Williams & Wilkins; 1996:309-397.
6. Harm DL. Physiology of motion sickness symptoms. In: Crampton GH (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:153-177.
7. Matsnev EI, Yakovleva IY, Tarasov IK, et al. Space motion sickness: Phenomenology, countermeasures, and mechanisms. Aviat Space Environ Med 1983; 54:312-317.
8. Oman CM, Lichtenberg BK, Money KE, et al. MIT/Canadian vestibular experiments on the Spacelab-1 mission: 4. Space motion sickness: Symptoms, stimuli, and predictability. Exp Brain Res 1986; 64:316-334.
9. Thornton WE, Linder BJ, Moore TP, et al. Gastrointestinal motility in space motion sickness. Aviat Space Environ Med 1987; 58: A16-A21.
10. Thornton WE, Moore TP, Pool SL, et al. Clinical characterization and etiology of space motion sickness. Aviat Space Environ Med 1987; 58:A1-A8.
11. Gorgiladze GI, Bryanov II. Space motion sickness. Kosm Biol Aviakosm Med 1989; 23:4-14.
12. Lackner JR, Graybiel A. Head movements in non-terrestrial force environments elicit motion sickness: Implications for the etiology of space motion sickness. Aviat Space Environ Med 1986; 57:443-448.
13. Lackner JR, Graybiel A. Head movements in low and high force environments elicit motion sickness: Implications for space motion sickness. Aviat Space Environ Med 1987; 58:A212-A217.
14. Lackner JR, Graybiel A, DiZio PA. Altered sensorimotor control of the body as an etiologic factor in space motion sickness. Aviat Space Environ Med 1991; 62:765-771.
15. Drummer C, Stromeyer H, Reipl RL, et al. Hormonal changes after parabolic flight: Implications on the development of motion sickness. Aviat Space Environ Med 1990; 61:821-828.
16. Rose BD. Acid base physiology. In: Rose BD (ed.), Clinical Physiology of Acid-Base and Electrolyte Disorders. New York, NY: McGraw-Hill; 1994:274-299.
17. Rose BD. Regulation of acid-base balance. In: Rose BD (ed.), Clinical Physiology of Acid-Base and Electrolyte Disorders. New York, NY: McGraw Hill; 1994:300-345.
18. Leach CS. Fluid control mechanisms in weightlessness. Aviat Space Environ Med 1987; 58:A74-A79.
19. Kohl RL, Homick JL. Motion sickness: A modulatory role for the central cholinergic nervous system. Neurosci Biobehav Rev 1983; 7:73-85.
20. Lathers CM, Charles JB, Bungo MW. Pharmacology in space. Part 2. Controlling motion sickness. Trends Pharmacol Sci 1989; 10:243-250.
21. Leach CS, Reschke MF. Biochemical correlates of neurosensory changes in weightlessness, 40th Congress of the International Astronautical Federation, Malaga, Spain, 1989. International Astronautical Federation.
22. Leach Huntoon C, Cintron NM, Whitson PA. Endocrine and biochemical functions. In: Nicogossian AE, Leach Huntoon C, Pool SL, (eds.), Space Physiology and Medicine, 3rd edn. Philadelphia, PA: Lea & Febiger; 1994:334-350.
23. Leach CS. Biochemical and hematological changes after shortterm space flight. Microgravity Quarterly. 1991; 2:69-75.
24. Hawkins WR, Zieglschmid JF. Clinical aspects of crew health. In: Johnston RS, Dietlein LF, Berry CA (eds.), Biomedical Results of Apollo. Washington, DC: U.S. Government Printing Office; 1975:43-81. NASA SP-368.
25. Davis JR, Vanderploeg JM, Santy PA, et al. Space motion sickness during 24 flights of the space shuttle. Aviat Space Environ Med 1988; 59:1185-1189.
26. Homick JL. Motion sickness: General background and methods, Space Adaptation Syndrome Drug Workshop, Houston, TX, 1985. Space Biomedical Research Institute, USRA Division of Space Biomedicine.
27. Dietlein LF. Summary and conclusions. In: Johnston RS, Dietlein LF, Berry CA (eds.), Biomedical Results of Apollo. Washington DC: U.S. Government Printing Office; 1975:571-579. NASA SP-368.
28. Jennings RT, Davis JR, Santy PA. Comparison of aerobic fitness and space motion sickness in the space shuttle program. Aviat Space Environ Med 1988; 58:448-451.
29. Simanonok KE, Kohl RL, Charles JB. The relationship between space sickness and preflight diet. Physiologist 1993; 36:S90-S91.
30. Homick JL. Space motion sickness. Acta Astronautica 1979; 6:1259-1272.
31. Kennedy RS, Graybiel A, McDonough RC, et al. Symptomatology under storm conditions in the North Atlantic in control subjects and in persons with bilateral labyrinthine defects. Acta Otolaryngol 1968; 66:533-540.
32. Igarashi M. Role of the vestibular end organs in experimental motion sickness: A primate model. In: Crampton GH (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:43-48.
33. Crampton GH. Neurophysiology of motion sickness. In: Crampton GH (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:29-42.
34. Guignard JC, McCauley ME. The accelerative stimulus for motion sickness. In: Crampton GH (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:123-152.
35. Dobie TG, May JG. Cognitive-behavioral management of motion sickness. Aviat Space Environ Med 1994; 65:C1-C2.
36. Mirabile CS. Motion sickness susceptibility and behavior. In: Crampton GH (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:391-410.
37. Kohl RL. Mechanisms of selective attention and space motion sickness. Aviat Space Environ Med 1987; 58:1130-1132.
38. Oman CM, Lichtenberg BK, Money KE. Space motion sickness monitoring experiment: Spacelab-1. In: Crampton GW (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:217-246.
39. Lackner JR, DiZio P. Altered sensory-motor control of the head as an etiological factor in space-motion sickness. Percept Mot Skills 1989; 68:784-786.
40. Johnson WH, Mayne JW. Stimulus required to produce motion sickness. Restriction of head movements as a preventative of airsickness-field studies on airborne troops. J Aviat Med 1953; 56:152-157.
41. Stott JRR. Adaptation to nauseogenic motion stimuli and its application in the treatment of airsickness. In: Crampton GH (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:373-390.
42. Welch RP. Adaptation of space perception. In: Boff KR, Kaufman L, Thomas JP (eds.), Handbook of Perception and Human Performance. Vol. 1. New York, NY: John Wiley & Sons; 1986:24-1-24-45.
43. Davis JE, Jennings RT, Beck BG. Comparison of treatment strategies for space motion sickness. Acta Astronautica 1993; 29:587-591.
44. Swisher S, Usher D, Andreae M, et al. Space in the Twenty First Century: Imperatives for the Decades of 1995-2015. Task Group on Life Sciences, National Research Council. Washington, DC: National Academy Press; 1988.
45. Bryanov II, Gorgiladze GI, Kornilova LN, et al. Vestibular function. In: Gazenko OG (ed.), Results of Medical Research Performed on the Salyut 6-Soyuz Orbital Scientific Research Complex. Moscow: Meditsina; 1986:169-185, 248-256.
46. Kornilova LN, Muller KH, Chernobylskiy LM. Phenomenology of illusory reactions in weightlessness. Fiziologiia Cheloveka 1995; 21:50-62.
47. Berry CA. View of human problems to be addressed for long duration space flights. Aerospace Med 1973; 44:1136-1146.
48. Yates BJ, Miller AD. Vestibular-Autonomic Regulation: CRC Press, Inc.; 1996:266.
49. Reason JT, Brand JJ. Motion Sickness. London: Academic Press; 1975.
50. Parker DE, Parker KL. Adaptation to the simulated stimulus rearrangement of weightlessness. In: Crampton GH (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:247-262.
51. Harm DL, Parker DE. Perceived self-orientation and self-motion in microgravity, after landing and during preflight adaptation training. J Vestib Res 1993; 3:297-305.
52. Harm DL, Parker DE, Reschke MF, et al. Relationship between selected orientation rest frame, circular vection and space motion sickness. Brain Res Bull 1998; 47:497-501.
53. Graybiel A, Lackner JR. Comparison of susceptibility to motion sickness during rotation at 30 rpm in the earth-horizontal 10° head-down position. Aviat Space Environ Med 1977; 48:7-11.
54. Graybiel A, Lackner JR. Rotation at 30 rpm about the z-Axis after 6 hours in the 10° head-down position: Effect on susceptibility to motion sickness. Aviat Space Environ Med 1979; 50:390-392.
55. Leach CS, Alfrew CP, Suki WN, et al. Regulation of body fluid compartments during short term spaceflight. J Appl Physiol 1996; 81:105-116.
56. Buckey JC, Gaffney FA, Lane LD, et al. Central venous pressure in space. J Appl Physiol 1996; 81:19-25.
57. Kornilova LN, Yakovleva IY, Tarasov IK, et al. Vestibular dysfunction in cosmonauts during adaptation to zero-g and readaptation to 1g. Physiologist 1983; 26:S35-S40.
58. von Baumgarten RJ, Welzig J, Vogel H, et al. Static and dynamic mechanisms of space vestibular malaise. Physiologist 1982; 25: S33-S36.
59. von Baumgarten RJ, Thumler RR. A Model for Vestibular Function in Altered Gravitational States, Open Meeting of the Working Group on Space Biology and Symposium on Gravitational Physiology, Life Sciences and Space Research, Innsbruck, Austria; 1978. Vol. XVII.
60. Diamond SG, Markham CH. Ocular torsion in upright and tilted positions during hypo-And hypergravity of parabolic flight. Aviat Space Environ Med 1988; 59:1158-1162.
61. Diamond SG, Markham CH, Money KE. Instability of ocular torsion in zero gravity: Possible implications for space motion sickness. Aviat Space Environ Med 1990; 61:899-905.
62. Diamond SG, Markham CH. Prediction of space motion sickness susceptibility by disconjugate eye torsion in parabolic flight. Aviat Space Environ Med 1991; 62:201-205.
63. Berry CA. Medical care of space crews (Medical care, equipment, and prophylaxis). In: Talbot JM, Genin AM (eds.), Space Medicine and Biotechnology. Vol. 3. Washington, DC: National Aeronautics and Space Administration; 1975:345-371. NASA SP-374. Calvin M, Gazenko OG (series eds.), Foundations of Space Biology and Medicine.
64. Wood CD, Graybiel A. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. Aerospace Med 1968; 39:1341-1344.
65. Attias J, Gordon C, Ribak J, et al. Efficacy of transdermal scopolamine against seasickness: A 3-day study at sea. Aviat Space Environ Med 1987; 58:60-62.
66. Offenloch K, Zahner G, Dietlein G, et al. Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions. Arzneimittelforschung 1986; 36:1401-1406.
67. Wood CD, Manno JE, Manno BR, et al. The effect of antimotion sickness drugs on habituation to motion. Aviat Space Environ Med 1986; 57:539-542.
68. Graybiel A. Space motion sickness: Skylab revisited. Aviat Space Environ Med 1980; 51:814-822.
69. Hordinsky JR, Schwertz E, Beier J, et al. Relative efficacy of the proposed space shuttle antimotion sickness medications. Acta Astronautica 1982; 6:375-383.
70. Lackner JR, Graybiel A. Use of promethazine to hasten adaptation to provocative motion. J Clin Pharmacol 1994; 34:644-648.
71. Reschke MF. Statistical prediction of space motion sickness. In: Crampton GH (ed.), Motion and Space Sickness. Boca Raton, FL: CRC Press, Inc.; 1990:263-316.
72. Harm DL, Parker DE. Preflight adaptation training for spatial orientation and space motion sickness. J Clin Pharmacol 1994; 34:618-627.
73. Harm DL, Reschke MF, Parker DE. Visual-vestibular integration: Motion perception reporting. In: Sawin CF, Taylor GR, Smith WL (eds.), Extended Duration Orbiter Medical Project. NASA/SP-1999-534. Houston, TX: NASA Johnson Space Center; 1999:5.2-1-5.2-12.
74. Lapayev EV, Vorobyev OA. The Problem of Vestibular Physiology in Aerospace Medicine and Prospects for Its Solution, Space Biology and Aerospace Medicine: 8th All-Union Conference, Kaluga; 1986. Nauka, Moscow.
75. Reschke MF, Parker DE, Harm DL, et al. Ground-based training for the stimulus rearrangement encountered during space flight. Acta Oto-Laryngologica (Stockholm) 1988; 460(Suppl.):87-93.
76. Ramsey HR. Human factors and artivicial gravity: A review. Hum Factors 1971; 13:533-542.
77. Bagian JP, Ward DF. A retrospective study of promethazine and its failure to produce the expected incidence of sedation during space flight. J Clin Pharmacol 1994; 34:649-651.